These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 25509932)
1. Global scale-up of the programmatic management of multidrug-resistant tuberculosis. Daley CL Indian J Tuberc; 2014 Apr; 61(2):108-15. PubMed ID: 25509932 [TBL] [Abstract][Full Text] [Related]
2. Management of multidrug-resistant tuberculosis: Update 2007. Yew WW; Leung CC Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909 [TBL] [Abstract][Full Text] [Related]
3. Multidrug resistant tuberculosis: trends and control. Prasad R; Gupta N; Singh M Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197 [TBL] [Abstract][Full Text] [Related]
4. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Pablos-Mendez A; Gowda DK; Frieden TR Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008 [TBL] [Abstract][Full Text] [Related]
5. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon]. Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681 [TBL] [Abstract][Full Text] [Related]
6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
7. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects. Yew WW Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001 [TBL] [Abstract][Full Text] [Related]
8. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Chang KC; Yew WW Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408 [TBL] [Abstract][Full Text] [Related]
9. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions. Prasad R Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
15. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Schaaf HS; Marais BJ Paediatr Respir Rev; 2011 Mar; 12(1):31-8. PubMed ID: 21172673 [TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis around the world: what progress has been made? Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Ahmad S; Mokaddas E Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927 [TBL] [Abstract][Full Text] [Related]
18. The global situation of MDR-TB. Espinal MA Tuberculosis (Edinb); 2003; 83(1-3):44-51. PubMed ID: 12758188 [TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistant tuberculosis among category I treatment failures--a retrospective study. Singh N; Sidiq Z; Bhalla M; Myneedu VP; Sarin R Indian J Tuberc; 2014 Apr; 61(2):148-51. PubMed ID: 25509938 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Gandhi NR; Nunn P; Dheda K; Schaaf HS; Zignol M; van Soolingen D; Jensen P; Bayona J Lancet; 2010 May; 375(9728):1830-43. PubMed ID: 20488523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]